pharmaceutical investing Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Apex Commences Drilling at Jersey Emerald Property and Announces Amendment to Terms of Lithium Creek Option Agreement
